Home › Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis clinical trials recruiting in the U.S.

27 studies for Idiopathic Pulmonary Fibrosis are recruiting participants at sites across the United States.

Cities with the most studies

• Birmingham, AL9 studies
• New York City, NY8 studies
• Kansas City, KS7 studies
• Los Angeles, CA7 studies
• Philadelphia, PA7 studies
• Durham, NC6 studies
• Chicago, IL6 studies
• Aurora, CO6 studies
• Charleston, SC5 studies
• Detroit, MI5 studies
• Atlanta, GA5 studies
• Nashville, TN5 studies
• Dallas, TX5 studies
• Houston, TX5 studies
• Salt Lake City, UT4 studies
• Newport Beach, CA4 studies
• Baltimore, MD4 studies
• Oklahoma City, OK4 studies
• Ann Arbor, MI4 studies
• Winston-Salem, NC4 studies
• El Paso, TX4 studies
• Boston, MA3 studies
• Denver, CO3 studies
• Pittsburgh, PA3 studies
• Champaign, IL3 studies
• Greensboro, NC3 studies
• Denison, TX3 studies
• Charlottesville, VA3 studies
• Orlando, FL3 studies
• Arlington, VA3 studies
• Richmond, VA3 studies
• Mountain View, CA3 studies
• New Haven, CT3 studies
• Cincinnati, OH3 studies

By state

• Alabama9 studies
• Arizona5 studies
• California12 studies
• Colorado9 studies
• Connecticut4 studies
• Florida10 studies
• Georgia5 studies
• Illinois8 studies
• Kansas7 studies
• Kentucky3 studies
• Louisiana4 studies
• Maryland4 studies
• Massachusetts4 studies
• Michigan7 studies
• Missouri6 studies
• New York8 studies
• North Carolina10 studies
• Ohio5 studies
• Oklahoma4 studies
• Oregon3 studies
• Pennsylvania12 studies
• South Carolina8 studies
• Tennessee6 studies
• Texas11 studies
• Utah5 studies
• Virginia8 studies
• Wisconsin3 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.